DICURAL TABLETS 45.4MG DIN 02242514
Status: Cancelled Post Market
Holder: BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Molecule: DIFLOXACIN (DIFLOXACIN HYDROCHLORIDE)
Health Canada record
| Active ingredient(s) | DIFLOXACIN (DIFLOXACIN HYDROCHLORIDE) 45.4 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 21-Dec-2001 |
| Current status date | 21-Jul-2014 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIFLOXACIN (DIFLOXACIN HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02242516 | DICURAL TABLETS 11.4MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | DIFLOXACIN (DIFLOXACIN HYDROCHLORIDE) 11.4 MG | Cancelled Post Market |
| 02242515 | DICURAL TABLETS 136MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | DIFLOXACIN (DIFLOXACIN HYDROCHLORIDE) 136 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11824 | 2010-10-29 | New Drug Submission (NDS) | Change in ownership |
| 9332 | 2008-01-30 | New Drug Submission (NDS) | CHANGE IN OWNERSHIP |
| 6482 | 2000-07-21 | New Drug Submission (NDS) |